Suggestions
Saryah Azmat
Oncology Business Development Executive
Saryah Azmat is the Chief Operating Officer at Turnstone Biologics, having been promoted from her previous role as Chief Business Officer, which she held since 2021. In her current position, she oversees business development, corporate strategy, and capital formation for the company, playing a crucial role in its growth and strategic initiatives, including the recent acquisition of Myst Therapeutics.12
Azmat's background includes significant experience in the biopharmaceutical industry. Before joining Turnstone, she worked at Bristol-Myers Squibb (BMS) as the Global Lead for Oncology Search & Evaluation. During her six years at BMS, she successfully executed over 15 major transactions across various stages of drug development. She also has experience as a consultant for Putnam Associates, where she managed projects for global biopharma clients.13
Her educational credentials include a Bachelor of Arts in Engineering Sciences and a Bachelor of Engineering in Biomedical Engineering from the Thayer School of Engineering at Dartmouth College.1
